Salem Almaani

3.0k total citations · 2 hit papers
36 papers, 1.3k citations indexed

About

Salem Almaani is a scholar working on Nephrology, Rheumatology and Molecular Biology. According to data from OpenAlex, Salem Almaani has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 13 papers in Rheumatology and 9 papers in Molecular Biology. Recurrent topics in Salem Almaani's work include Renal Diseases and Glomerulopathies (17 papers), Systemic Lupus Erythematosus Research (12 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers). Salem Almaani is often cited by papers focused on Renal Diseases and Glomerulopathies (17 papers), Systemic Lupus Erythematosus Research (12 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers). Salem Almaani collaborates with scholars based in United States, Canada and Argentina. Salem Almaani's co-authors include Brad H. Rovin, Alexa Meara, Sergey V. Brodsky, Samir V. Parikh, David Jayne, Lynn A. Fussner, Isabelle Ayoub, Lee A. Hebert, Kim Jordan and John O. Elliott and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Salem Almaani

32 papers receiving 1.3k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update on Lupus Nephritis

2016 595 citations Salem Almaani, Alexa Meara et al. Clinical Journal of the American Society of Nephrology profile →
Update on Lupus Nephritis: Core Curriculum 2020

2020 284 citations Samir V. Parikh, Salem Almaani et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salem Almaani United States	13	824	559	529	223	167	36	1.3k
Juan M. Mejía‐Vilet Mexico	19	525 0.6×	498 0.9×	310 0.6×	156 0.7×	183 1.1×	54	1.0k
Suzanne Wilhelmus Netherlands	9	733 0.9×	589 1.1×	505 1.0×	82 0.4×	118 0.7×	16	1.0k
Allen R. Hendricks United States	8	600 0.7×	239 0.4×	446 0.8×	129 0.6×	72 0.4×	16	913
Jared Hassler United States	5	601 0.7×	249 0.4×	448 0.8×	123 0.6×	65 0.4×	7	898
Cristina Arriens United States	19	725 0.9×	219 0.4×	470 0.9×	126 0.6×	41 0.2×	40	1.0k
Juanita Romero‐Díaz Mexico	17	1.0k 1.2×	199 0.4×	639 1.2×	85 0.4×	62 0.4×	50	1.3k
Laura Lisk United States	12	943 1.1×	759 1.4×	344 0.7×	41 0.2×	145 0.9×	17	1.3k
Irene Cecchi Italy	18	731 0.9×	174 0.3×	275 0.5×	174 0.8×	70 0.4×	83	1.1k
Wan-zhong Zou China	17	421 0.5×	737 1.3×	237 0.4×	223 1.0×	417 2.5×	49	1.2k
Hélène Beaufils France	15	492 0.6×	631 1.1×	148 0.3×	211 0.9×	301 1.8×	24	1.1k

Countries citing papers authored by Salem Almaani

Since Specialization

Citations

This map shows the geographic impact of Salem Almaani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salem Almaani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salem Almaani more than expected).

Fields of papers citing papers by Salem Almaani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salem Almaani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salem Almaani. The network helps show where Salem Almaani may publish in the future.

Co-authorship network of co-authors of Salem Almaani

This figure shows the co-authorship network connecting the top 25 collaborators of Salem Almaani. A scholar is included among the top collaborators of Salem Almaani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salem Almaani. Salem Almaani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Helmuth, Margaret, Salem Almaani, Isabelle Ayoub, et al.. (2025). Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN). Kidney International Reports. 10(6). 1917–1928. 1 indexed citations

Mottl, Amy K., Andrew S. Bomback, Laura H. Mariani, et al.. (2023). CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes. SHILAP Revista de lepidopterología. 3(1). 155–164. 1 indexed citations

Wong, Alexander, Xueliang Pan, Salem Almaani, et al.. (2023). Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis. Clinical and Experimental Rheumatology. 42(4). 811–815. 1 indexed citations

Zhao, Qiuhong, Naresh Bumma, Rami Kahwash, et al.. (2022). Functional Impairments of Amyloidosis Patients: Physical Therapy Assessment. SHILAP Revista de lepidopterología. 3(3). 414–421. 2 indexed citations

Caster, Dawn J., et al.. (2022). Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study. Journal of the American Society of Nephrology. 33(11S). 498–498. 2 indexed citations

Parikh, Samir V., Ana Malvar, Huijuan Song, et al.. (2022). Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis. Kidney International. 102(4). 845–865. 27 indexed citations

Kitamura, Mineaki, Salem Almaani, Isabelle Ayoub, et al.. (2022). The Diagnostic Conundrum of Glomerular Crescents With IgA Deposits. Kidney International Reports. 8(3). 507–518. 2 indexed citations

Almaani, Salem, Sethu M. Madhavan, John P. Shapiro, et al.. (2021). Comparison of Glomerular Proteomics Profiles of Healthy Human Kidney and Minimal Change Disease Identifies Distinct Targets and Pathways. Journal of the American Society of Nephrology. 32(10S). 445–445. 2 indexed citations

Madhavan, Sethu M., Salem Almaani, John P. Shapiro, et al.. (2021). Differentiating Steroid-Sensitive Minimal Change Disease and Primary and Secondary Focal Segmental Glomerulosclerosis: A Proteomics-Based Approach. Journal of the American Society of Nephrology. 32(10S). 31–31. 2 indexed citations

10.

Palmer, Matthew B., Amin Abedini, Shatakshee Chatterjee, et al.. (2021). The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort. Kidney International Reports. 6(4). 1066–1080. 21 indexed citations

11.

Almaani, Salem, Lynn A. Fussner, Sergey V. Brodsky, Alexa Meara, & David Jayne. (2021). ANCA-Associated Vasculitis: An Update. Journal of Clinical Medicine. 10(7). 1446–1446. 96 indexed citations

12.

Almaani, Salem, Samir V. Parikh, Anjali A. Satoskar, et al.. (2021). Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits. Kidney International Reports. 6(8). 2203–2206. 12 indexed citations

13.

Vasylyeva, Tetyana L., Salem Almaani, Isabelle Ayoub, et al.. (2021). Evaluation of the Reproductive Care Provided to Adolescent Patients in Nephrology Clinics: A Pediatric Nephrology Research Consortium Study. Kidney International Reports. 6(5). 1411–1415. 5 indexed citations

14.

Parikh, Samir V., Salem Almaani, Sergey V. Brodsky, & Brad H. Rovin. (2020). Update on Lupus Nephritis: Core Curriculum 2020. American Journal of Kidney Diseases. 76(2). 265–281. 284 indexed citations breakdown →

15.

Almaani, Salem, Udayan Bhatt, Cristina Arriens, et al.. (2020). Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints. Kidney International Reports. 5(8). 1302–1305.

16.

Ayoub, Isabelle, John P. Shapiro, Huijuan Song, et al.. (2020). Establishing a Case for Anti-complement Therapy in Membranous Nephropathy. Kidney International Reports. 6(2). 484–492. 18 indexed citations

17.

Zhao, Qiuhong, Don M. Benson, Patrick Elder, et al.. (2020). AL Amyloidosis: The Prognostic Impact of Maintenance Therapy Following ASCT. Biology of Blood and Marrow Transplantation. 26(3). S229–S230. 1 indexed citations

18.

Almaani, Salem, Stephenie D. Prokopec, Jianying Zhang, et al.. (2019). Rethinking Lupus Nephritis Classification on a Molecular Level. Journal of Clinical Medicine. 8(10). 1524–1524. 23 indexed citations

19.

Almaani, Salem & Samir V. Parikh. (2019). Membranous Lupus Nephritis: A Clinical Review. Advances in Chronic Kidney Disease. 26(5). 393–403. 27 indexed citations

20.

Almaani, Salem, Alexa Meara, & Brad H. Rovin. (2016). Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 12(5). 825–835. 595 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact